GGrantIndex
Sort

51,593 grants matching hepatitis

Impacts of universal access to HIV/AIDS care among HIV+ injection drug users

$540,708
M-J Milloy · University Of British Columbia · U01 · FY2023 · DA

Emerging Infections Programs-ARRA-317

$540,700
Richard Norman Danila · Minnesota State Dept Of Health · U01 · FY2009 · CI

ALTERATIONS OF NEUROENDOCRINE STRESS RESPONSIVITY IN SPECIFIC ADDICTIVE DISEAS...

$540,699
Mary J Kreek · Rockefeller University · P60 · FY2008 · DA

Role of liver fat and fibrosis in human CVD risk phenotypes.

$540,686
Rohit Loomba · University Of California, San Diego · P01 · FY2024 · HL

Optimizing Benefits While Reducing Risks of Iron in Malaria-Endemic Areas

$540,677
Sarah Cusick · University Of Minnesota · R01 · FY2019 · HD

Kalamazoo Community Clinical Oncology Program

$540,631
Raymond S Lord · West Michigan Cancer Center · U10 · FY2009 · CA

Targeting matrix stiffness in lung and liver fibrosis

$540,586
Daniel J. Tschumperlin · Mayo Clinic Rochester · R01 · FY2016 · HL

Management and Treatment of Chronic Delta Hepatitis Infection and other Liver Diseases

$540,582
Christopher Koh · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

Project 1: Post-Shock Mesenteric Lymph and the 5-Lipoxygenase Pathway

$540,517
Ernest E Moore · University Of Colorado Denver · P50 · FY2013 · GM

Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis

$540,508
Gianfranco D. Alpini · Indiana University Indianapolis · R01 · FY2021 · AA

Funct character of GABA_B receptor modulators, drug metabolism, pharmacokinetics

$540,469
Patrick Robert Griffin · University Of California, San Diego · U19 · FY2010 · DA

Virtual and Augmented Reality Guidance for Hepatic RFA

$540,466
University Of North Carolina Chapel Hill · R01 · FY2005 · CA

Preclinical Testing of Human Ghrelin and Growth Hormone for Sepsis in the Elderly

$540,425
Weng-Lang Yang · Therasource, Llc · R44 · FY2017 · AG

Preclinical Testing of Human Ghrelin and Growth Hormone for Sepsis in the Elderly

$540,425
Weng-Lang Yang · Therasource, Llc · R44 · FY2016 · AG

Pediatric Clinical Research Scholar Program - Washington

$540,299
Children'S Research Institute · K12 · FY2002 · RR

QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload

$540,298
Yi Wang · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · DK

Mechanistic roles of Cytochrome P4501A enzymes in hyperoxic lung injury

$540,275
Bhagavatula Moorthy · Baylor College Of Medicine · R01 · FY2016 · HL

Visceral Adiposity, HIV, and HCV: Biologic Mediators of Hepatic Steatosis

$540,263
Phyllis C Tien · Northern California Institute/Res/Edu · R01 · FY2011 · AI

Nutrition Infection and Hepatic Carbohydrate Metabolism

$540,255
Owen P McGuinness · Vanderbilt University · R01 · FY2011 · DK

Injectable Hydrogel Depots for Self-replicating mRNA Vaccine Delivery

$540,184
James D. Bryers · University Of Washington · R01 · FY2022 · AI

Injectable Hydrogel Depots for Self-replicating mRNA Vaccine Delivery

$540,184
James D. Bryers · University Of Washington · R01 · FY2024 · AI

Injectable Hydrogel Depots for Self-replicating mRNA Vaccine Delivery

$540,184
James D. Bryers · University Of Washington · R01 · FY2023 · AI

ENTEROHEPATIC LIPID FLUX AND APOPROTEIN BIOSYNTHESIS.

$540,171
Nicholas Davidson · Washington University · R37 · FY2007 · HL

Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2

$540,155
David E Cohen · Brigham And Women'S Hospital · R37 · FY2014 · DK

Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2

$540,155
David E Cohen · Brigham And Women'S Hospital · R37 · FY2015 · DK